Miyasaka Kiyoyuki W, Suzuki Yasuyuki, Brown Emery N, Nagasaka Yasuko
Department of Anesthesia, St Luke's International Hospital, Tokyo, Japan.
Department of Anesthesia, Tokyo Women's Medical University, Tokyo, Japan.
JAMA Pediatr. 2025 Apr 21. doi: 10.1001/jamapediatrics.2025.0517.
Pediatric anesthesia emergence delirium (PAED) is a common complication of general anesthesia and has unknown etiology. Exposure to volatile anesthetics may contribute to PAED, and excessive exposure may occur frequently during routine pediatric anesthesia.
To examine whether use of electroencephalography (EEG) monitoring can reduce PAED by minimizing exposure to sevoflurane while maintaining a state of unconsciousness under anesthesia.
DESIGN, SETTING, AND PARTICIPANTS: A single-center, parallel-group, 2-arm, superiority randomized clinical trial with a 1:1 allocation ratio was conducted from October 13, 2021, to March 18, 2023, at an academic tertiary pediatric hospital in Japan. The follow-up period was 24 ± 6 hours postoperatively or uneventful discharge to home, whichever came first. The observer for the primary outcome was blinded to patient assignment. The trial included a convenience sample of children aged 1 to younger than 6 years undergoing general anesthesia for procedures for which reliable antinociception can be provided. Data analysis was performed in March 2023.
EEG-guided titration of anesthesia to minimize sevoflurane exposure (EEG-guided group) vs standard 1.0-minimum alveolar concentration (MAC) sevoflurane anesthesia (control group).
Proportion of patients who developed PAED, defined by a maximum PAED score of 10 or higher.
Of the 177 participants who completed follow-up, 125 (71%) were male and 52 (29%) were female. The EEG-guided group included 91 participants (mean [SD] age, 2.9 [1.5] years), and the control group included 86 participants (mean [SD] age, 2.8 [1.6] years). In the EEG-guided group, sevoflurane exposure was reduced by 1.4 MAC-hours (96.65% CI, 1.1 to 1.6 MAC-hours). A total of 30 (35%) in the control group and 19 (21%) in the EEG-guided group developed PAED (difference, 14%; 96.65% CI, -0.0019% to 28%; 95% CI, 0.92% to 27%; P = .04). Children in the EEG-guided group emerged a mean of 21.4 minutes (96.65% CI, 15.4 to 27.4 minutes) earlier from general anesthesia and spent a mean of 16.5 minutes less (96.65% CI, 10.8 to 22.3 minutes less) in the postanesthesia care unit.
EEG-guided management of general anesthesia reduced sevoflurane exposure and pediatric anesthesia emergence delirium in children, with faster emergence and shorter postanesthesia care unit stays. The findings suggest that high concentrations of sevoflurane for induction followed by routine use of 1.0-MAC sevoflurane for maintenance may be excessive.
Japan Registry of Clinical Trials Identifier: jRCTs032210248.
小儿麻醉苏醒期谵妄(PAED)是全身麻醉常见的并发症,病因不明。接触挥发性麻醉剂可能导致PAED,在常规小儿麻醉期间可能经常发生过度接触。
研究脑电图(EEG)监测的使用是否可以通过在维持麻醉下无意识状态的同时尽量减少七氟醚接触来降低PAED。
设计、设置和参与者:2021年10月13日至2023年3月18日,在日本一家学术性三级儿童医院进行了一项单中心、平行组、双臂、优效性随机临床试验,分配比例为1:1。随访期为术后24±6小时或顺利出院回家,以先到者为准。主要结局的观察者对患者分组情况不知情。该试验纳入了一个便利样本,即年龄在1至6岁以下、接受全身麻醉进行可提供可靠镇痛的手术的儿童。数据分析于2023年3月进行。
EEG引导下滴定麻醉以尽量减少七氟醚接触(EEG引导组)与标准1.0最低肺泡浓度(MAC)七氟醚麻醉(对照组)。
PAED评分最高为10分或更高定义的发生PAED的患者比例。
在完成随访的177名参与者中,125名(71%)为男性,52名(29%)为女性。EEG引导组包括91名参与者(平均[标准差]年龄,2.9[1.5]岁),对照组包括86名参与者(平均[标准差]年龄,2.8[1.6]岁)。在EEG引导组中,七氟醚接触减少了1.4 MAC小时(96.65%可信区间,1.1至1.6 MAC小时)。对照组共有30名(35%)患者发生PAED,EEG引导组有19名(21%)患者发生PAED(差异为14%;96.65%可信区间,-0.0019%至28%;95%可信区间,0.92%至27%;P = 0.04)。EEG引导组的儿童全身麻醉苏醒平均提前21.4分钟(96.65%可信区间,15.4至27.4分钟),在麻醉后护理单元的停留时间平均减少16.5分钟(96.65%可信区间,少10.8至22.3分钟)。
EEG引导下的全身麻醉管理减少了儿童的七氟醚接触和小儿麻醉苏醒期谵妄,苏醒更快,在麻醉后护理单元的停留时间更短。研究结果表明,诱导时使用高浓度七氟醚,随后常规使用1.0-MAC七氟醚维持麻醉可能过度。
日本临床试验注册中心标识符:jRCTs032210248